Phase 2 Study of Radiation Therapy Plus Low Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420

PURPOSE: Evaluate the toxicity and efficacy of adjuvant temozolomide (TMZ) and irinotecan (CPT-11) for 12 months following concurrent chemo-radiation in newly diagnosed glioblastoma (GBM). METHODS: Trial RTOG 04-20, a single arm, multi-institutional phase 2 trial was designed to determine the effica...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Radiat Oncol Biol Phys
Autors principals: Lieberman, Frank S, Wang, Meihua, Robins, H Ian, Tsien, Christina I, Curran, Walter J, Werner-Wasik, Maria, Smith, Ryan P, Schultz, Christopher, Hartford, Alan C, Zhang, Peixin, Mehta, Minesh P
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7034757/
https://ncbi.nlm.nih.gov/pubmed/30496882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2018.11.008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars